Clinical and Angiographic Outcomes Following Percutaneous Coronary Intervention With Sirolimus-Eluting Stents Versus Bare-Metal Stents in Hemodialysis Patients

American Journal of Kidney Diseases

Volumn 54, Issue 2, 2009, Pages 299-306

  Yachi, Sen ^a   Tanabe, Kengo ^a   Tanimoto, Shuzou ^a   Aoki, Jiro ^a   Nakazawa, Gaku ^a   Yamamoto, Hirosada ^a   Otsuki, Shuji ^a   Yagishita, Atsuhiko ^a   Kishi, Satoru ^a   Nakano, Masataka ^a   Taniwaki, Masahiro ^a   Sasaki, Shunsuke ^a   Nakajima, Hiroyoshi ^a   Mise, Naofumi ^a   Sugimoto, Tokuichiro ^a   Hara, Kazuhiro ^a  

^a MITSUI MEMORIAL HOSPITAL   (Japan)

Author keywords

Hemodialysis; intervention; stent

Indexed keywords

RAPAMYCIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CAUSE OF DEATH; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEMODIALYSIS; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; REVASCULARIZATION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSTHESIS DESIGN; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SIROLIMUS;

EID: 67650432182     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.01.263     Document Type: Article

References (28)

1. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
2. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
3. Schampaert E., Cohen E.A., Schluter M., et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 43 (2004) 1110-1115
4. Schofer J., Schluter M., Gershlick A.H., et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS). Lancet 362 (2003) 1093-1099
5. Daemen J., Lemos P., Aoki J., et al. Treatment of coronary artery disease in dialysis patients with sirolimus-eluting stents: 1-Year clinical follow-up of a consecutive series of cases. J Invasive Cardiol 16 (2004) 685-687
6. Hassani S.E., Chu W.W., Wolfram R.M., et al. Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients. J Invasive Cardiol 18 (2006) 273-277
7. Nakazawa G., Tanabe K., Aoki J., et al. Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents. Catheter Cardiovasc Interv 69 (2007) 808-814
8. Mishkel G.J., Varghese J.J., Moore A.L., Aguirre F., Markwell S.J., and Shelton M. Short- and long-term clinical outcomes of coronary drug-eluting stent recipients presenting with chronic renal disease. J Invasive Cardiol 19 (2007) 331-337
9. Halkin A., Selzer F., Marroquin O., Laskey W., Detre K., and Cohen H. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. J Invasive Cardiol 18 (2006) 577-583
10. Das P., Moliterno D.J., Charnigo R., et al. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J Invasive Cardiol 18 (2006) 405-408
11. Nakazawa G., Tanabe K., Aoki J., et al. Clinical and angiographic outcomes of sirolimus-eluting stent implantation in Japanese patients in daily practice. Circ J 70 (2006) 1367-1371
12. Mehran R., Dangas G., Abizaid A.S., et al. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation 100 (1999) 1872-1878
13. Cutlip D.E., Windecker S., Mehran R., et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 115 (2007) 2344-2351
14. Le Feuvre C., Dambrin G., Helft G., et al. Comparison of clinical outcome following coronary stenting or balloon angioplasty in dialysis versus non-dialysis patients. Am J Cardiol 85 (2000) 1365-1368
15. Herzog C.A., Ma J.Z., and Collins A.J. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 106 (2002) 2207-2211
16. Blacher J., Guerin A.P., Pannier B., Marchais S.J., Safar M.E., and London G.M. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99 (1999) 2434-2439
17. Blacher J., London G.M., Safar M.E., and Mourad J.J. Influence of age and end-stage renal disease on the stiffness of carotid wall material in hypertension. J Hypertens 17 (1999) 237-244
18. Schwartz R.S., Murphy J.G., Edwards W.D., Camrud A.R., Vliestra R.E., and Holmes D.R. Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries. Circulation 82 (1990) 2190-2200
19. Hoffmann R., Mintz G.S., Mehran R., et al. Tissue proliferation within and surrounding Palmaz-Schatz stents is dependent on the aggressiveness of stent implantation technique. Am J Cardiol 83 (1999) 1170-1174
20. Sabo R.S., Bartoli F., and Apitz-Castro R. In vivo platelet hyperreactivity, another risk factor for patients under continuous ambulatory peritoneal dialysis. Nephron 49 (1988) 228-230
21. Viener A., Aviram M., Better O.S., and Brook J.G. Enhanced in vitro platelet aggregation in hemodialysis patients. Nephron 43 (1986) 139-143
22. Notohamiprodjo M., Andrassy K., Bommer J., and Ritz E. Dialysis membranes and coagulation system. Blood Purif 4 (1986) 130-141
23. Lin Y.F., Chang D.M., Shaio M.F., et al. Cytokine production during hemodialysis: Effects of dialytic membrane and complement activation. Am J Nephrol 16 (1996) 293-299
24. Schettler V., Wieland E., Methe H., Schuff-Werner P., and Muller G.A. Oxidative stress during dialysis: Effect on free radical scavenging enzyme (FRSE) activities and glutathione (GSH) concentration in granulocytes. Nephrol Dial Transplant 13 (1998) 2588-2593
25. Horl W.H., Steinhauer H.B., and Schollmeyer P. Plasma levels of granulocyte elastase during hemodialysis: Effects of different dialyzer membranes. Kidney Int 28 (1985) 791-796
26. Aoyama T., Ishii H., Toriyama T., et al. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J 72 (2008) 56-60
27. Popma J.J., Leon M.B., Moses J.W., et al. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation 110 (2004) 3773-3780
28. Ishio N., Kobayashi Y., Takebayashi H., et al. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J 71 (2007) 1525-1529